Radiotherapy-Associated Atrial Fibrillation (RADAF)

Istanbul University

Status: Completed

Conditions: Atrial Fibrillation New Onset

Treatments: Diagnostic Test: ECG

Study type: Observational

Funder types: Other

Identifiers

NCT05927246

COEXIST-1

Details and patient eligibility

About

Radiotherapy associated Atrial Fibrillation (RADAF) is an observational study to evaluate onset time and frequency of atrial fibrillation in patients with thoracic malignancies and breast cancer.

Each patient will have 12 lead ECG prior, and daily during radiotherapy.

Full description

Collected data will be truly anonymised and individuals will no longer identifiable, and than evaluated for occurrence of atrial fibrillation.

Inclusing Criteria:

1. Patients with radiotherapy for thoracic malignancy or breast cancer
2. Between 18-99 years-old

Exclusion Criteria:

1. Patients with history of radiotherapy
2. Patients with history of atrial fibrillation
3. Patients with pacemaker implantation

Enrollment: 400 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with radiotherapy for thoracic malignancy or breast cancer
• Between 18-99 years-old

Exclusion criteria

• Patients with history of radiotherapy
• Patients with history of atrial fibrillation
• Patients with pacemaker implantation

Trial design

400 participants in 2 patient groups

Patients with Thoracic Malignancies

Description:

All patients undergoing RT for Thoracic Malignancies

Treatment:

Diagnostic Test: ECG

Patients with Breast Cancer

Description:

All patients undergoing RT for Breast Cancer

Treatment:

Diagnostic Test: ECG